Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances
- PMID: 27651100
- DOI: 10.1615/CritRevTherDrugCarrierSyst.2016014850
Chitosan Nanoparticles Prepared by Ionotropic Gelation: An Overview of Recent Advances
Abstract
The objective of this review is to summarize recent advances in chitosan nanoparticles prepared by ionotropic gelation. Significant progress has occurred in this area since the method was first reported. The gelation technique has been improved through a number of creative methodological modifications. Ionotropic gelation via electrospraying and spinning disc processing produces nanoparticles with a more uniform size distribution. Large-scale manufacturing of the nanoparticles can be achieved with the latter approach. Hydrophobic and hydrophilic drugs can be simultaneously encapsulated with high efficiency by emulsification followed by ionic gelation. The turbulent mixing approach facilitates nanoparticle formation at a relatively high polymer concentration (5 mg/mL). The technique can be easily tuned to achieve the desired polymer/surface modifications (e.g., blending, coating, and surface conjugation). Using factorial-design-based approaches, optimal conditions for nanoparticle formation can be determined with a minimum number of experiments. New insights have been gained into the mechanism of chitosan-tripolyphosphate nanoparticle formation. Chitosan nanoparticles prepared by ionotropic gelation tend to aggregate/agglomerate in unfavorable environments. Factors influencing this phenomenon and strategies that can be adopted to minimize the instability are discussed. Ionically cross-linked nanoparticles based on native chitosan and modified chitosan have shown excellent efficacy for controlled and targeted drug-delivery applications.
Similar articles
-
Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.Colloids Surf B Biointerfaces. 2012 Feb 1;90:21-7. doi: 10.1016/j.colsurfb.2011.09.042. Epub 2011 Oct 2. Colloids Surf B Biointerfaces. 2012. PMID: 22014934
-
Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers.Carbohydr Polym. 2013 May 15;94(2):940-5. doi: 10.1016/j.carbpol.2013.02.013. Epub 2013 Feb 18. Carbohydr Polym. 2013. PMID: 23544653
-
Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate.Mol Pharm. 2012 Oct 1;9(10):2856-62. doi: 10.1021/mp300162j. Epub 2012 Sep 4. Mol Pharm. 2012. PMID: 22845012
-
Advances in preparation and characterization of chitosan nanoparticles for therapeutics.Artif Cells Nanomed Biotechnol. 2016;44(1):305-14. doi: 10.3109/21691401.2014.948548. Epub 2014 Aug 19. Artif Cells Nanomed Biotechnol. 2016. PMID: 25137489 Review.
-
Chitosan-based nanoparticles as drug delivery systems: a review on two decades of research.J Drug Target. 2019 Apr;27(4):379-393. doi: 10.1080/1061186X.2018.1512112. Epub 2018 Sep 5. J Drug Target. 2019. PMID: 30103626 Review.
Cited by
-
Potential of Pullulan-Based Polymeric Nanoparticles for Improving Drug Physicochemical Properties and Effectiveness.Polymers (Basel). 2024 Jul 29;16(15):2151. doi: 10.3390/polym16152151. Polymers (Basel). 2024. PMID: 39125177 Free PMC article. Review.
-
Nanoparticles as a Solution for Eliminating the Risk of Mycotoxins.Nanomaterials (Basel). 2018 Sep 14;8(9):727. doi: 10.3390/nano8090727. Nanomaterials (Basel). 2018. PMID: 30223519 Free PMC article. Review.
-
A Fibrinogen-Mimicking, Activated-Platelet-Sensitive Nanocoacervate Enhances Thrombus Targeting and Penetration of Tissue Plasminogen Activator for Effective Thrombolytic Therapy.Adv Healthc Mater. 2022 Oct;11(19):e2201265. doi: 10.1002/adhm.202201265. Epub 2022 Jul 31. Adv Healthc Mater. 2022. PMID: 35864062 Free PMC article.
-
Tuning of Hydrogel Architectures by Ionotropic Gelation in Microfluidics: Beyond Batch Processing to Multimodal Diagnostics.Biomedicines. 2021 Oct 27;9(11):1551. doi: 10.3390/biomedicines9111551. Biomedicines. 2021. PMID: 34829780 Free PMC article.
-
Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer.Bioact Mater. 2020 Sep 8;6(2):433-446. doi: 10.1016/j.bioactmat.2020.08.019. eCollection 2021 Feb. Bioact Mater. 2020. PMID: 32995671 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical